Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $1.79B | 28,748,255 | 40.80% | 59.20% | Net Selling | Net Selling | ||
| ELTX | ELICIO THERAPEUTICS INC | $189.85M | 18,396,074 | 11.31% | 62.00% | Net Buying | |||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.22B | 86,022,028 | 75.83% | 0.00% | ||||
| MGNX | MACROGENICS INC | $186.85M | 63,555,837 | 62.39% | 37.61% | Net Buying | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.58B | 47,792,943 | 76.59% | 23.41% | Net Selling | Net Selling | ||
| BLZE | BACKBLAZE INC | $241.19M | 57,700,000 | 55.77% | 21.24% | Net Selling | Net Selling | ||
| XNCR | XENCOR INC | $852.20M | 73,338,642 | 71.97% | 28.03% | Net Selling | Net Selling | ||
| PCOR | PROCORE TECHNOLOGIES INC | $8.40B | 150,100,482 | 35.21% | 64.79% | Net Selling | Net Selling | ||
| ASST | STRIVE INC | $996.58M | 69,158,785 | 39.45% | 60.55% | Net Buying | Net Buying | ||
| PHAR | PHARMING GROUP NV | $1.15B | 701,680,440 | 0.02% | 0.00% | ||||
| EXOD | EXODUS MOVEMENT INC | $210.77M | 29,811,917 | 10.34% | 15.56% | Net Selling | Net Selling | ||
| AGBK | AGI INC | $1.36B | 183,566,434 | 0.00% | 1.99% | ||||
| TRVI | TREVI THERAPEUTICS INC | $1.77B | 128,397,271 | 43.05% | 56.95% | Net Buying | |||
| CABA | CABALETTA BIO INC | $309.48M | 111,322,671 | 68.49% | 3.91% | Net Buying | |||
| WALD | WALDENCAST PLC | $97.85M | 128,237,613 | 16.55% | 13.18% | ||||
| AGMB | AGOMAB THERAPEUTICS NV | $523.43M | 48,736,779 | 0.00% | 0.09% | ||||
| IRON | DISC MEDICINE INC | $2.52B | 38,160,065 | 60.49% | 39.51% | Net Selling | Net Selling | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.88B | 140,032,190 | 82.92% | 9.83% | Net Selling | Net Selling | ||
| DMRA | DAMORA THERAPEUTICS INC | $1.44B | 60,303,212 | 1.84% | 27.36% | Net Selling | |||
| TLX | TELIX PHARMACEUTICALS LTD | $3.53B | 338,777,049 | 0.33% | 7.54% | ||||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.32B | 114,883,096 | 60.18% | 39.82% | Net Buying | Net Selling | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $147.23M | 57,288,750 | 65.18% | 34.82% | Net Buying | Net Buying | ||
| ERAS | ERASCA INC | $2.83B | 310,799,547 | 70.55% | 27.68% | Net Buying | Net Buying | ||
| MGPI | MGP INGREDIENTS INC | $409.47M | 21,371,237 | 25.36% | 74.64% | Net Selling | Net Selling | ||
| CPS | COOPER-STANDARD HOLDINGS INC | $511.47M | 17,637,009 | 66.18% | 20.02% | Net Selling | Net Selling | ||
| BLSH | BULLISH | $5.51B | 150,833,916 | 23.84% | 10.03% | Net Selling | Net Selling | ||
| DC | DAKOTA GOLD CORP | $707.64M | 133,517,177 | 37.43% | 20.61% | Net Buying | Net Buying | ||
| BIOA | BIOAGE LABS INC | $748.24M | 44,379,753 | 53.01% | 22.30% | Net Selling | Net Buying | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $207.94M | 131,608,278 | 22.19% | 11.13% | Net Buying | Net Buying | ||
| ARVN | ARVINAS INC | $628.10M | 63,960,997 | 70.83% | 29.17% | Net Selling | Net Selling | ||
| PEPG | PEPGEN INC | $107.13M | 69,115,292 | 83.00% | 9.75% | Net Buying | Net Selling | ||
| DEFT | DEFI TECHNOLOGIES INC | $290.91M | 385,827,975 | 11.74% | 0.00% | ||||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.10B | 373,321,692 | 0.01% | 22.93% | ||||
| RLMD | RELMADA THERAPEUTICS INC | $773.04M | 104,890,223 | 49.23% | 3.37% | Net Buying | |||
| PERI | PERION NETWORK LTD | $400.79M | 39,024,964 | 57.66% | 1.42% | Net Selling | Net Selling | ||
| IPX | IPERIONX LTD | $977.02M | 336,322,679 | 0.95% | 0.75% | Net Buying | Net Buying | ||
| KWR | QUAKER CHEMICAL CORP | $2.31B | 17,335,075 | 55.90% | 44.10% | Net Selling | Net Selling | ||
| CNTX | CONTEXT THERAPEUTICS INC | $215.00M | 91,879,177 | 70.98% | 1.43% | Net Buying | |||
| ABVX | ABIVAX SA | $8.34B | 78,536,412 | 71.68% | 0.00% | ||||
| BILL | BILL HOLDINGS INC | $3.69B | 98,960,440 | 85.40% | 14.60% | Net Selling | Net Selling | ||
| TYRA | TYRA BIOSCIENCES INC | $1.82B | 53,867,115 | 62.54% | 37.46% | Net Buying | Net Selling | ||
| ELAN | ELANCO ANIMAL HEALTH INC | $10.84B | 497,168,077 | 91.17% | 8.83% | Net Selling | Net Selling | ||
| WPM | WHEATON PRECIOUS METALS CORP | $56.70B | 454,033,830 | 63.61% | 0.00% | ||||
| DCGO | DOCGO INC | $69.82M | 98,750,251 | 42.20% | 26.53% | Net Selling | Net Selling | ||
| MARA | MARA HOLDINGS INC | $4.08B | 380,234,635 | 65.96% | 11.17% | Net Selling | Net Selling | ||
| CLFD | CLEARFIELD INC | $381.96M | 13,685,411 | 60.37% | 39.63% | Net Buying | Net Selling | ||
| NKTX | NKARTA INC | $191.77M | 71,290,490 | 61.06% | 38.94% | Net Selling | |||
| LTM | LATAM AIRLINES GROUP SA | $26.94B | 574,215,983,709 | 0.00% | 0.00% | ||||
| NEXN | NEXXEN INTERNATIONAL LTD | $207.69M | 56,284,083 | 65.34% | 2.52% | ||||
| MMED | MINIMED GROUP INC | $3.38B | 280,819,988 | 0.00% | 90.31% | Net Selling | Net Selling | ||
| LBRX | LB PHARMACEUTICALS INC | $877.16M | 28,674,827 | 76.06% | 23.94% | Net Buying | |||
| KRRO | KORRO BIO INC | $181.87M | 14,422,571 | 19.15% | 80.85% | Net Buying | Net Buying | ||
| SLDB | SOLID BIOSCIENCES INC | $693.66M | 98,391,314 | 55.24% | 44.76% | Net Selling | Net Selling | ||
| PCVX | VAXCYTE INC | $8.25B | 143,920,361 | 88.01% | 11.99% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $777.76M | 60,526,128 | 56.33% | 43.67% | Net Buying | Net Selling | ||
| CGTX | COGNITION THERAPEUTICS INC | $105.44M | 89,353,773 | 24.06% | 30.41% | Net Selling | Net Selling | ||
| CRVO | CERVOMED INC | $33.79M | 9,258,719 | 3.05% | 96.95% | Net Buying | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $447.76M | 113,933,436 | 23.17% | 76.83% | Net Buying | |||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $449.76M | 51,051,487 | 80.75% | 19.25% | Net Buying | Net Selling | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.65B | 81,642,394 | 77.04% | 22.96% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.